Covered recipient · General Payments record
DRAKE EVERSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$574.17
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $193.65 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $60.86 | 4 |
| Novo Nordisk AS | $40.40 | 2 |
| Abbott Laboratories | $18.66 | 1 |
| ABBVIE INC. | $17.14 | 1 |
| PFIZER INC. | $14.95 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.47 | 1 |
| Acerta Pharma LLC | $13.92 | 1 |
| GlaxoSmithKline, LLC. | $13.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.66 | 02/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124931287 | CMS |
| ABBVIE INC. | $17.14 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103703409 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.92 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105673445 | CMS |
| GlaxoSmithKline, LLC. | $13.25 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115725397 | CMS |
| Lilly USA, LLC | $16.68 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136162301 | CMS |
| Lilly USA, LLC | $14.05 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136174084 | CMS |
| Lilly USA, LLC | $15.19 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136174976 | CMS |
| Lilly USA, LLC | $14.94 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136163758 | CMS |
| Novo Nordisk Inc | $16.98 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096787850 | CMS |
| Novo Nordisk Inc | $23.42 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096785807 | CMS |
| PFIZER INC. | $14.95 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131667821 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.47 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137542315 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.